Abstract
Background It has been documented that women are under-represented as speakers at emergency medicine conferences globally. This lack of opportunity is likely contributing to the gender gap of women in academic and leadership positions.
Methods The Gender-Specific Issues Special Interest Group (GSI-SIG) of the International Federation of Emergency Medicine (IFEM) has analyzed the gender distribution of invited speakers, plenary speakers, and organizing committees from its last three International Conferences on Emergency Medicine in 2016, 2018, and 2019.
Results Men comprised 75% (range 57-92%) of organizing committees, 69% (67-70%) of plenary speakers, and 78% (range 75-81%) of invited speakers.
Conclusion The percentage of women speakers at IFEM’s International Conferences on Emergency Medicine is low; even below the percentage of women emergency medicine physicians. By understanding these data and their consequences, changes can be made to close this gender gap and create more equitable opportunities for women and their career advancement.
Strengths and Limitations of this study
The gender breakdown of local organizing committee members and invited speakers at three consecutive International Conferences on Emergency Medicine heavily favoured men over women.
Having women on the host country’s local organizing committee had no effect on the gender distribution of speakers.
As these conferences draw speakers and participants from a diverse, international audience, the results are generalizable.
The organizing committee and speakers’ backgrounds (MD, RN, paramedic) were not delineated, and may have skewed the results.
Gender non-conforming individuals were not identified.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB not requires as no no patients nor subjects were involved.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos